Effects of acupoint-injection of Kaixilai on TG, TC, MDA, SOD, AST and ALT in the patient of non-alcoholic fatty liver / 中国针灸

ABSTRACT

<p><b>OBJECTIVE</b>To observe therapeutic effect of acupoint-injection of Kaixilai on non-alcoholic fatty liver.</p><p><b>METHODS</b>One hundred cases of non-alcoholic fatty liver were randomly divided into a test group and a control group, 50 cases in each group. The test group were treated with injection of 2 mL Kaixilai injection into Zusanli (ST 36), thrice each week, for 3 months; and the control group were treated with intravenous drip of 200 mL Kaixilai injection, once each day, for 3 months. Changes of triglyceride (TG), total cholesterol (TC), malondialhyde (MDA), superoxide dismutase (SOD), glutamic-oxaloacetic transaminase (AST), glutamic-pyruvic transaminase (ALT), and clinical symptoms were observed in the two groups.</p><p><b>RESULTS</b>There were significant differences before and after treatment in the symptoms, TG, TC, MDA, SOD, AST and ALT in the two groups (P<0.05), with no significant difference between the two groups (P>0.05).</p><p><b>CONCLUSION</b>Acupoint-injection of Kaixilai is an effective therapy for non-alcoholic fatty liver, with convenience, economic and no adverse effect.</p>